The cytokine IL-6 has been suggested as one of the most promising immunological markers that might be useful as additional factor for prediction of radiation-induced normal tissue toxicity6,19,21, not only for prostate cancer, but also for other types of cancer. This evidence concerns the gene IL6 and prostate cancer.